Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    In: Journal of Medical Biochemistry, Centre for Evaluation in Education and Science (CEON/CEES), Vol. 35, No. 1 ( 2016-01-1), p. 7-16
    Abstract: Background: Brain-derived neurotrophic factor (BDNF) and nitric oxide (NO) play multiple roles in the developing and adult CNS. Since BDNF and NO metabolisms are dysregulated in schizophrenia, we measured these markers simultaneously in the blood of schizophrenics and assessed their diagnostic accuracy. Methods: Thirty-eight patients with schizophrenia classified according to demographic characteristics, symptomatology and therapy and 39 age- and gender-matched healthy controls were enrolled. BDNF was determined by the ELISA technique while the concentration of nitrite/nitrate (NO - 2 /NO - 3 ) was measured by the colorimetric method. Results: Serum BDNF levels were significantly lower (20.38±3.73 ng/mL, P=1.339E-05), whilst plasma NO - 2 /NO - 3 concentrations were significantly higher (84.3 (72-121) mmol/L, P=4.357E-08) in patients with schizophrenia than in healthy controls (25.65±4.32 ng/mL; 60.9 (50-76) mmol/L, respectively). The lowest value of BDNF (18.14±3.26 ng/mL) and the highest NO - 2 /NO - 3 concentration (115.3 (80-138) mmol/L) were found in patients treated with second-generation antipsychotics (SGA). The patients diseased before the age of 24 and the patients suffering for up to one year had significantly lower serum BDNF levels than those diseased after the age of 24 and the patients who were ill longer than one year. Both BDNF and NO - 2 /NO - 3 showed good diagnostic accuracy, but BDNF had better ROC curve characteristics, especially in patients with negative symptomatology. Conclusions: BDNF and nitrite/nitrate showed inverse changes in schizophrenic patients. The most pronounced changes were found in patients treated with second-gene - ration antipsychotics. Although BDNF is not specific of schizophrenia, it may be a clinically useful biomarker for the diagnosis of patients expressing predominantly negative symptoms.
    Type of Medium: Online Resource
    ISSN: 1452-8266
    Language: Unknown
    Publisher: Centre for Evaluation in Education and Science (CEON/CEES)
    Publication Date: 2016
    detail.hit.zdb_id: 2405112-3
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. Further information can be found on the KOBV privacy pages